T2DM
Clinical trials for T2DM explained in plain language.
Never miss a new study
Get alerted when new T2DM trials appear
Sign up with your email to follow new studies for T2DM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New diabetes drug HM15275 enters Mid-Stage trial
Disease control Not yet recruitingThis study tests a new medicine called HM15275 in 180 adults with type 2 diabetes. Participants must be on diet and exercise or a stable dose of metformin. The goal is to see if the drug safely lowers blood sugar levels over 36 weeks compared to a placebo.
Matched conditions: T2DM
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New drug aims to protect kidneys in diabetes patients
Disease control Not yet recruitingThis study tests whether an investigational drug called HTD1801 can slow the worsening of kidney disease in adults who have both type 2 diabetes and chronic kidney disease. About 75 participants will receive either HTD1801 or a placebo twice daily for 12 weeks. Researchers will m…
Matched conditions: T2DM
Phase: PHASE2 • Sponsor: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
Sleep and menopause may harm diabetic women's hearts – study aims to find out how
Knowledge-focused Not yet recruitingThis study looks at how menopause and poor sleep change the heart's structure and function in women with type 2 diabetes. Researchers will track 381 women aged 48-58 using heart scans and sleep data. The goal is to understand these links, not to test a new treatment.
Matched conditions: T2DM
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC